Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 21, 2020
Twitter and Haemophilia
Mike Makris
Research and Practice in Thrombosis and Haemostasis
|
July 21, 2020
Staying updated on COVID-19: Social media to amplify science in thrombosis and hemostasis
Mike Makris
Blood Transfusion = Trasfusione Del Sangue
|
February 17, 2012
Prophylaxis in haemophilia should be life-long
Mike Makris
British Journal of Haematology
|
October 11, 2014
Is the continued use of UK plasma sourced cryoprecipitate justified?
Mike Makris
Blood Transfusion = Trasfusione Del Sangue
|
August 15, 2012
Factor V Leiden: to test or not to test, that is the debate
Mike Makris
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 11, 2022
The 2021 von Willebrand disease guidelines: Clarity and controversy
Mike Makris, Cedric Hermans
Research and Practice in Thrombosis and Haemostasis
|
April 14, 2025
Hemophilia treatments and the paradox of choice
Mike Makris, Brian O'Mahony
Journal of Thrombosis and Haemostasis : JTH
|
April 1, 2021
Making treatment decisions in hemophilia based on available safety data
Mike Makris, Cedric Hermans
Research and Practice in Thrombosis and Haemostasis
|
May 24, 2021
Disruptive technology and hemophilia care: The multiple impacts of emicizumab
Cedric Hermans, Mike Makris
British Journal of Haematology
|
December 29, 2018
Haemophilia and ageing
Susan Shapiro, Mike Makris
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 21, 2020
Twitter and Haemophilia
Mike Makris
Research and Practice in Thrombosis and Haemostasis
|
July 21, 2020
Staying updated on COVID-19: Social media to amplify science in thrombosis and hemostasis
Mike Makris
Blood Transfusion = Trasfusione Del Sangue
|
February 17, 2012
Prophylaxis in haemophilia should be life-long
Mike Makris
British Journal of Haematology
|
October 11, 2014
Is the continued use of UK plasma sourced cryoprecipitate justified?
Mike Makris
Blood Transfusion = Trasfusione Del Sangue
|
August 15, 2012
Factor V Leiden: to test or not to test, that is the debate
Mike Makris
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 11, 2022
The 2021 von Willebrand disease guidelines: Clarity and controversy
Mike Makris, Cedric Hermans
Research and Practice in Thrombosis and Haemostasis
|
April 14, 2025
Hemophilia treatments and the paradox of choice
Mike Makris, Brian O'Mahony
Journal of Thrombosis and Haemostasis : JTH
|
April 1, 2021
Making treatment decisions in hemophilia based on available safety data
Mike Makris, Cedric Hermans
Research and Practice in Thrombosis and Haemostasis
|
May 24, 2021
Disruptive technology and hemophilia care: The multiple impacts of emicizumab
Cedric Hermans, Mike Makris
British Journal of Haematology
|
December 29, 2018
Haemophilia and ageing
Susan Shapiro, Mike Makris
Page
of 9